4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-026457
Options or other derivatives
- Interim CEO & General Counsel acquired 235,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2026-03-09 | Grant or award · Restricted Stock Units | +235,000 | 235,000 | D: show line 1 in the form |
Loading xslF345X05/tm268453-6_4seq1.xml…